Nanomedicines for the Treatment of CNS Diseases Jessica L. ReynoldsRam I. Mahato GUEST COMMENTARY 01 February 2017 Pages: 1 - 5
Perspectives on Dual Targeting Delivery Systems for Brain Tumors Huile Gao PERSPECTIVE 08 June 2016 Pages: 6 - 16
Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art Luisa FiandraAmedeo CapettiFabio Corsi INVITED REVIEW 10 November 2016 Pages: 17 - 30
Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection Catherine DeMarinoAngela SchwabFatah Kashanchi INVITED REVIEW 02 July 2016 Pages: 31 - 50
Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery Chaitanya R. JoshiVinod LabhasetwarAnuja Ghorpade INVITED REVIEW 03 February 2017 Pages: 51 - 83
Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology Jianing MengVivek AgrahariIbrahima Youm INVITED REVIEW 23 July 2016 Pages: 84 - 98
Cell Mediated Photothermal Therapy of Brain Tumors Henry HirschbergSteen J. Madsen INVITED REVIEW 11 June 2016 Pages: 99 - 106
Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier – from Targeting to Safe Administration Maria João GomesCarlos FernandesBruno Sarmento ORIGINAL ARTICLE 21 May 2016 Pages: 107 - 119
Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood–Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro Myosotys RodriguezAjeet KaushikMadhavan Nair ORIGINAL ARTICLE 10 June 2016 Pages: 120 - 132
Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 “Nanoplex” a Possible Neurotherapeutic? Ravikumar AalinkeelCourtney S. MangumSupriya D. Mahajan ORIGINAL ARTICLE 27 December 2016 Pages: 133 - 151
Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats Ana Lucía Rodríguez-PereaJohanna Gutierrez-VargasPaula Andrea Velilla Hernández ORIGINAL ARTICLE 10 September 2016 Pages: 152 - 162
Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation Mahmoud L. SolimanJonathan D. GeigerXuesong Chen BRIEF REPORT 15 September 2016 Pages: 163 - 170
A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat Kristen A. McLaurinLandhing M. MoranCharles F. Mactutus BRIEF REPORT 03 October 2016 Pages: 171 - 179
B Lymphocytes Express Pomc mRNA, Processing Enzymes and β-Endorphin in Painful Inflammation Santhosh Chandar MaddilaMelanie Busch-DienstfertigChristoph Stein BRIEF REPORT 11 November 2016 Pages: 180 - 186
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis A. CalcagnoA. RomitoS. Bonora BRIEF REPORT 08 November 2016 Pages: 187 - 193
Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis Ross PenninkilampiHolly M. BrothersGuy D. Eslick BRIEF REPORT 26 December 2016 Pages: 194 - 203
Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study Christian RitterMartin K. R. SvačinaHelmar C. Lehmann BRIEF REPORT 01 February 2017 Pages: 204 - 209
Erratum to: Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats Ana Lucía Rodríguez-PereaJohanna Gutierrez-VargasPaula Andrea Velilla Hernández Erratum 14 October 2016 Pages: 210 - 210